A Resin‐Linker‐Vector Approach to Radiopharmaceuticals Containing 18F: Application in the Synthesis of O‐(2‐[18F]‐Fluoroethyl)‐L‐tyrosine |
| |
Authors: | Dr Amy C Topley Valerio Isoni Dr Thomas A Logothetis Dr Duncan Wynn Dr Harry Wadsworth Dr Alex M R Gibson Imtiaz Khan Dr Neil J Wells Prof Cécile Perrio Prof Richard C D Brown |
| |
Institution: | 1. Department of Chemistry, University of Southampton, Southampton, Hampshire, SO17 1BJ (U.K.), Fax: (+44)?23‐80597574;2. GE Healthcare, The Grove Centre, White Lion Road, Amersham, Bucks, HP7 9?LL (U.K.);3. Laboratoire de Développements Méthodologiques en TEP, CNRS, Université de Caen‐Basse Normandie, Cyceron, Bd Henri Becquerel, 14074 CAEN Cedex 5 (France) |
| |
Abstract: | A Resin‐linker‐vector (RLV) strategy is described for the radiosynthesis of tracer molecules containing the radionuclide 18F, which releases the labelled vector into solution upon nucleophilic substitution of a polystyrene‐bound arylsulfonate linker with 18F]‐fluoride ion. Three model linker‐vector molecules 7 a – c containing different alkyl spacer groups were assembled in solution from (4‐chlorosulfonylphenyl)alkanoate esters, exploiting a lipase‐catalysed chemoselective carboxylic ester hydrolysis in the presence of the sulfonate ester as a key step. The linker‐vector systems were attached to aminomethyl polystyrene resin through amide bond formation to give RLVs 8 a – c with acetate, butyrate and hexanoate spacers, which were characterised by using magic‐angle spinning (MAS) NMR spectroscopy. On fluoridolysis, the RLVs 8 a , b containing the longer spacers were shown to be more effective in the release of the fluorinated model vector (4‐fluorobutyl)phenylcarbamic acid tert‐butyl ester ( 9 ) in NMR kinetic studies and gave superior radiochemical yields (RCY≈60 %) of the 18F‐labelled vector. The approach was applied to the synthesis of the radiopharmaceutical O‐(2‐18F]‐fluoroethyl)‐L ‐tyrosine (18F]‐FET), delivering protected 18F]‐FET in >90 % RCY. Acid deprotection gave 18F]‐FET in an overall RCY of 41 % from the RLV. |
| |
Keywords: | amino acids positron‐emission tomography radiochemistry radiopharmaceuticals solid‐phase synthesis |
|
|